Coenzyme Q

DRUG3 trials

Sponsors

National Institute on Aging (NIA), University of Iowa, Sherief Abd-Elsalam

Conditions

ADHDAlzheimer's DiseaseMultiple Sclerosis

Phase 1

Anti-Oxidant Treatment of Alzheimer's Disease

CompletedNCT00117403

National Institute on Aging (NIA)Alzheimer's Disease

Start: 2006-01-31End: 2007-09-30Target: 75Updated: 2009-04-03

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

CompletedNCT01381354

University of IowaMultiple Sclerosis

Start: 2010-10-31End: 2016-05-31Updated: 2018-06-26

Phase 3

Role of Coenzyme Q in ADHD in Children

RecruitingNCT04216186

Sherief Abd-ElsalamADHD

Start: 2018-11-01End: 2030-12-01Target: 40Updated: 2020-01-02

Related Papers

Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorderin Children: A Randomized Controlled Trial

CNS & Neurological Disorders - Drug Targets2021-11-255 citations

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

2012-07-01255 citations